🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial compares the impact of brentuximab vedotin and nivoluma...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-12-04
Trial ID
NCT07572123
Treatments Being Tested
This phase III trial studies how well chemotherapy and radiation therapy (c...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2019-07-26
Trial ID
NCT03811002
This randomized phase III trial is studying whole-brain radiation therapy a...
Status
Terminated
Location
Arizona Oncology Services Foundation
Start Date
2004-10-06
Trial ID
NCT00096265
RATIONALE: Androgens can cause the growth of prostate cancer cells. Androge...
Status
Active Not Recruiting
Location
University of South Alabama Mitchell Cancer Institute
Start Date
2011-07
Trial ID
NCT01368588
This randomized phase II trial studies how well dose-escalated photon inten...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-12-04
Trial ID
NCT02179086
Treatments Being Tested
An explanatory study comparing complementary treatment to breast conservati...
Status
Active Not Recruiting
Location
Unidad Medica de Alta Especialidad
Start Date
2021-04-26
Trial ID
NCT05318274
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness of the three mos...
Status
Active Not Recruiting
Location
Instituto Catalán de Oncología
Start Date
2003-04
Trial ID
NCT01492751
This prospective, multicenter, nonrandomized phase-II-trial investigates in...
Status
Recruiting
Location
Leiden University Medical Center
Start Date
2022-05-02
Trial ID
NCT05406856
The purpose of this study is to compare the efficacy and toxicity of early ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2022-12-01
Trial ID
NCT05524389
Treatments Being Tested